FDA
approval
· 2022-04-29
FDA Approved: TRI-LINYAH — Supplemental Application (Northstar Rx LLC)
Summary
FDA approved a supplemental application for TRI-LINYAH (norgestimate and ethinyl estradiol) submitted by Northstar Rx LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRI-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)